Maxim lowered the firm’s price target on Laird Superfood (LSF) to $6 from $8 and keeps a Buy rating on the shares. The company’s Navitas acquisition completed on March 12 represents a growth catalyst that nearly doubles combined revenue and creates a compelling superfood product portfolio, though the firm is reducing its price target due to dilution related to the Navitas acquisition financing, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LSF:
- Morning Movers: AstraZeneca jumps following tozorakimab trial results
- Laird Superfood Earnings Call: Growth, Navitas And Dilution
- Closing Bell Movers: Argan jumps 10% on earnings beat
- Laird Superfood reports Q4 EPS (16c) vs (4c) last year
- Laird Superfood sees FY26 combined revenue growth at least in high single digits